Methylene blue test: what each type means

You take your methylene blue, wait a few hours, and then notice your urine is a vivid blue-green. Natural question: is that a good sign? Is the compound working? Is something wrong?

Or maybe you're not worried about urine at all. You're holding a bottle of methylene blue you bought online and wondering if what's inside is actually pharmaceutical grade, or whether you just paid for something with more arsenic than active compound. You want to test it, but you're not sure how.

Or you're scheduled for a drug screen at work and you've read somewhere that methylene blue might show up. You don't know if that's real or a myth.

All three questions involve testing methylene blue in some form. And they're very different questions with very different answers. This guide covers all of them, plus the formal clinical "methylene blue test" that dates back decades in medicine. Understanding which kind of test you're dealing with, and what it actually tells you, makes you a smarter, safer user of this compound.

Let's start with the question most people have first.

The urine test: why your pee turns blue

Methylene blue is an intense dye. That's not a metaphor. It was originally developed in the 1870s as a textile dye before researchers discovered it had remarkable biological properties. When you take it orally, your kidneys filter it from your bloodstream and excrete it in your urine. And because it's such a potent dye, the color shows up clearly.

Most users see blue or blue-green urine somewhere between two and six hours after taking methylene blue. The color intensity depends on your dose, your hydration level, and your kidney filtration rate.

What color means what

At typical longevity doses of 4-30 mg, expect a blue-green tint. At higher doses, the urine often turns a deeper, more saturated blue. Very low doses, think 2-5 mg, might produce only a faint greenish hue. That happens because your urine already contains urochrome, a yellow pigment. Yellow plus blue equals green. The blue compound mixes with the yellow background and produces a green or blue-green result depending on concentration.

Some users see purple rather than blue. That typically indicates the methylene blue is interacting with another compound in the urine, sometimes hydroxocobalamin (a form of B12) or certain medications. If you're taking hydroxocobalamin alongside methylene blue, purple urine is documented and not a cause for alarm. It's worth mentioning to your doctor if you're on any prescription medications and see unexpected color changes.

Does blue urine mean the methylene blue is working?

Here's where most people get confused. Blue urine proves the compound is present in your system and that your kidneys are clearing it. That's all it proves.

It does not confirm you're getting mitochondrial benefits. It does not confirm you hit the therapeutic dose range. It doesn't tell you anything about your brain function or your NAD+ levels or your cellular energy production.

Your body actually converts part of the methylene blue you ingest into leucomethylene blue, a colorless reduced form. This conversion happens continuously, and leucomethylene blue is the active form for electron cycling in the mitochondria. So clear or light urine could actually mean your body is efficiently using and converting the compound. And vivid blue urine could simply mean excess is being cleared without full utilization.

The urine test is a presence test, not a performance test. Think of it like a GPS signal indicator showing you're connected to satellites. It doesn't tell you how well the navigation is working, just that the signal exists.

What if your urine stays completely clear?

If you take methylene blue and see no color change at all after several hours, a few explanations are possible.

Your dose might be very low. Sub-5 mg doses often don't produce visible color at normal hydration levels because dilution is too high. If you're well-hydrated and took a low dose, clear urine is expected.

You might be taking a poorly formulated capsule with low bioavailability. Some methylene blue products use binding agents or formulations that impair release. Capsule forms vary considerably in how effectively they release the compound in the GI tract.

You might simply have highly efficient renal clearance, filtering and excreting it so efficiently at a diluted concentration that color doesn't show. This is less common but not unusual in young, well-hydrated individuals with strong kidney function.

What it doesn't automatically mean: that your methylene blue is fake or reagent grade. Grade doesn't determine urine color. A contaminated reagent-grade product could still produce blue urine. Quality and urine color are separate questions.

How to test methylene blue quality before you take it

This is the test that actually matters for your safety. Not urine color. Quality verification.

The methylene blue supplement market is poorly regulated. "Pharmaceutical grade," "USP grade," "99.9% pure," and similar claims appear on product labels without any requirement to back them up. Behind some of these labels is genuine pharmaceutical-grade material manufactured under Good Manufacturing Practices, tested by independent labs, with verified Certificates of Analysis. Behind others is reagent-grade or laboratory-grade methylene blue made for industrial staining, legally containing heavy metals at concentrations that would fail any pharmaceutical review.

Those are not scare tactics. Published analysis of non-pharmaceutical methylene blue samples has confirmed arsenic levels far exceeding safe limits alongside elevated copper, zinc, and detectable mercury. The synthesis chemistry of methylene blue involves metal-based oxidizing agents and produces heavy metal contamination as a byproduct. Pharmaceutical manufacturing is specifically designed to test for and eliminate this contamination. Reagent manufacturing isn't, because it doesn't need to be. Nobody drinks reagent grade. Until now, apparently.

For a deep breakdown of exactly what contamination looks like across grades and what the specific toxic thresholds are, the USP grade methylene blue guide covers the full analysis. Here we'll focus on the practical verification tests you can actually run.

The Certificate of Analysis test

The most reliable quality test isn't a home test at all. It's documentation.

Every legitimate pharmaceutical-grade or USP-grade methylene blue product should have a Certificate of Analysis (CoA) available for each production batch. This document records what was in the product when the manufacturer (or a third-party laboratory) tested it. A real CoA is your evidence.

What a legitimate CoA shows:

• Batch or lot number specific to the product you purchased (not a generic template)
• Assay result confirming the methylene blue content falls in the 98.0-103.0% range required by USP standards
• Heavy metal results with specific ppm measurements for arsenic (should be under 2.15 ppm), copper (under 55 ppm), and other metals
• Residual solvent testing for methylene chloride, chloroform, trichloroethylene, and 1,4-dioxane, all known or probable carcinogens present in the synthesis process
• Testing laboratory name and accreditation, ideally ISO/IEC 17025 certified
• Analyst signature and test date

Request this document from any supplier before buying. If they can't or won't provide it, that's your answer. Some vendors will point you to a generic CoA on their website that clearly applies to no specific batch. That's not adequate. You want lot-specific documentation.

The gold standard is double verification: the manufacturer tests the raw material, and then an independent third-party laboratory tests the finished product from that same batch. Companies like Troscriptions document exactly this process. Their Just Blue and Tro+ Blue troches use methylene blue they describe as "beyond USP grade," tested at the manufacturing level and re-tested independently. Troscriptions methylene blue troches are one of the most thoroughly documented options in the consumer market.

WinAging exists specifically to dig into these quality differences and give longevity-focused users the information they need to make decisions that actually serve their health goals. Grade verification is one of the most important pre-purchase checks for any compound you plan to take long-term.

The visual inspection test

Before CoA documentation became widely discussed in the biohacking community, visual inspection was the primary quality signal. It's still useful as a first filter.

Pharmaceutical-grade methylene blue solution in water should be clear and bright blue-violet. The color should be consistent throughout the solution with no cloudiness, brown tinting, or visible particulate matter.

Brown or greenish discoloration in a liquid product suggests the methylene blue has oxidized to its reduced leucomethylene form, which is colorless, or formed sulfoxide impurities, which are brownish. An oxidized product has degraded and its therapeutic activity is compromised. This is often the result of improper storage (exposure to light, heat, or oxygen), poor formulation, or age.

Cloudiness suggests possible contamination or incompatible excipients in the formulation. A properly prepared pharmaceutical solution should be transparent.

For powder products, authentic methylene blue powder should be a consistent dark greenish-blue color with a metallic bronze sheen under light. This is actually a key optical property of the compound: it appears dark and somewhat metallic in powder form but dissolves to a vivid blue in solution. If the powder is dull black, brown, or gray with no metallic quality, that's worth investigating.

The GMP and facility verification test

If you want to go deeper than the CoA, verify the manufacturing facility itself.

Good Manufacturing Practice (GMP) certification at the production facility means the entire manufacturing process, not just the final product, has been audited against pharmaceutical production standards. Look for NSF certification, ISO 9001, or pharmaceutical GMP certification from a recognized auditing organization.

Compounding pharmacies represent the highest tier of quality assurance for most users. A licensed compounding pharmacy operating under state pharmacy board oversight that formulates methylene blue is subject to the regulatory infrastructure of the pharmaceutical system. Accessing this route typically requires a physician's prescription. If you're working with a functional medicine doctor or longevity-focused physician, asking about compounding pharmacy options is worth it.

The pharmaceutical-grade methylene blue capsules guide covers specific compounding pharmacy options and the differences between over-the-counter supplement products and prescription-compounded formulations.

The price test

This isn't definitive on its own, but it's a useful signal. USP-grade methylene blue costs more to produce than reagent grade. The raw material costs more. The testing costs more. GMP certification costs more. The finished product naturally costs more.

If you find methylene blue at a price significantly below what other USP-grade suppliers charge, that gap has to come from somewhere. It's either a genuine retail bargain from a brand taking thin margins, or something in the production process was cut. Given that quality testing is often the first cost to get cut, low price is worth additional scrutiny rather than celebration.

Compare price per milligram across several known reputable suppliers before forming a price expectation. Anything far below that baseline deserves a closer look at the CoA.

How to assess whether methylene blue is actually working

You've verified the grade. You've started your protocol. Now you want to know if it's doing anything.

This is a harder test than it sounds, for a few reasons.

First, the benefits of methylene blue at longevity doses are largely subclinical. You're not going to feel your mitochondria generating more ATP. You won't notice your cytochrome oxidase activity increasing. Most of the longevity-oriented benefits are either subtle in the short term or measurable only through biomarkers.

Second, methylene blue has a hormetic dose-response. Low doses enhance cellular function. Higher doses do the opposite. If you're at a dose that's too high, you might not feel worse in an obvious way, but you're potentially outside the beneficial range. The sweet spot is typically 4-30 mg daily for ongoing use.

Third, placebo effects are strong for cognitive compounds, and methylene blue has genuine cognitive effects that users feel relatively quickly. Separating placebo from real effect is genuinely difficult without controlled testing.

Cognitive indicators to track

The most commonly reported subjective effect from methylene blue is a mild improvement in focus and mental clarity, particularly in the first one to three hours after dosing. Some users describe a slight increase in alertness without the edginess of stimulants. Others report improved word retrieval and reduced mental fatigue during cognitively demanding tasks.

If you're experiencing these effects, track them systematically rather than relying on memory. A daily note about focus quality, mental energy, and cognitive performance at the same time each day gives you actual data over a month of use. Any compound that's genuinely working should show a pattern. Confirmation bias on longevity supplements is real, and honest self-tracking corrects for it.

Objective cognitive benchmarking

For more objective measurement, consider cognitive testing tools designed to track performance over time. Cambridge Brain Sciences and Quantified Mind offer free cognitive batteries you can repeat weekly. Running these before you start methylene blue, during your first month, and after six months gives you something to compare against.

Research on methylene blue and cognition is promising. A randomized double-blind trial in healthy subjects found a 7% improvement in memory retrieval with a single high dose. Lower-dose human studies are limited, but animal models consistently show robust effects on memory consolidation and neuroprotection at low doses. The mechanism is real: methylene blue crosses the blood-brain barrier and acts directly on the mitochondrial electron transport chain in neurons, preserving cytochrome oxidase activity. Your subjective experience is worth tracking, but it represents only part of what's happening biologically.

Biological age markers

For longer-term effect assessment, biological age markers provide more meaningful data than any subjective test. Compounds like methylene blue are theoretically operating on mechanisms related to mitochondrial efficiency, oxidative stress, and cellular energy, all of which correlate with biological aging.

Testing relevant biomarkers before starting and after six to twelve months of consistent use gives you actual signal. Track HbA1c (insulin sensitivity), hsCRP (inflammation), fasting glucose, and a lipid panel at minimum. If you're more advanced, telomere length testing or epigenetic clock testing provides a direct biological age readout.

The biological age calculator is a good starting point for establishing your baseline before adding new compounds to your protocol. And if you're building a broader longevity stack, the WinAging protocol builder can help you design a compound combination based on your specific goals, age, and biomarker profile.

What stacking with red light therapy does to the response

There's a specific interaction worth knowing about. Methylene blue is a photosensitizer: it absorbs light energy in the red and near-infrared spectrum and transfers that energy to biological molecules. Some biohackers combine low-dose oral methylene blue with red light therapy sessions specifically to exploit this property, reasoning that the compound will channel photon energy into mitochondrial electron cycling during the session.

The formal evidence for this specific oral-dose-plus-red-light protocol is limited. But the mechanistic basis is real, and the methylene blue red light therapy guide covers the research and practical implementation for anyone interested in this synergy.

The drug test question: will methylene blue flag a screen?

Methylene blue doesn't contain the compounds tested for on standard workplace drug screens. It's not a controlled substance. Standard urine drug tests look for metabolites of cannabis (THC-COOH), opioids, amphetamines, cocaine (benzoylecgonine), PCP, and benzodiazepines. Methylene blue produces none of these metabolites.

But there's a complication worth knowing.

Because methylene blue changes urine color, a drug testing technician who notices vividly blue or green urine may flag the sample as adulterated or substituted. Many drug testing protocols include visual inspection of the sample. Blue or green urine is unusual enough to prompt further investigation even if the drug panel comes back clean.

This doesn't mean you'll fail the drug test. It means you may be asked for an explanation. Some testing facilities may request a second sample. The outcome depends entirely on the facility's protocols for unusual specimens.

The practical solution is simple: disclose that you're taking methylene blue before the test. If you're subject to workplace drug screening, let the testing administrator know in advance. Methylene blue is not a controlled or prohibited substance. It has legitimate medical uses and is legally available as a supplement. Disclosing its use beforehand avoids any questions about the sample color.

At very low doses (4-8 mg), urine color may not be visibly blue at all during a midday or afternoon test. The compound's excretion peak is typically 2-6 hours post-dose. If you dose in the morning and test in the afternoon with good hydration, the color may have diluted below visible threshold. But this isn't reliable enough to count on, and disclosure is still the right approach.

One additional note: standard methylene blue does not interact with or invalidate immunoassay drug tests from a chemical standpoint. The dye doesn't cross-react with the antibodies used in ELISA-based urine screening for common drugs of abuse. What you're managing is the technician's visual response to unusual urine color, not a false positive on the chemistry.

For the serotonin interaction warning that's more clinically important: methylene blue is a MAO-A inhibitor and cannot be safely combined with SSRIs, SNRIs, MAOIs, tricyclic antidepressants, or tramadol. That's not a drug test issue, but it's the interaction that matters most for your safety. If you're on any of these medications, the interaction risk is serious enough to require a physician's guidance before taking methylene blue. The what to avoid when taking low dose naltrexone guide illustrates how carefully interaction awareness needs to be applied across longevity compounds generally.

The clinical methylene blue test: its use in medicine

While supplement users focus on urine color and quality verification, clinicians have used methylene blue as a diagnostic tool for decades.

The most established clinical use is testing the integrity of anastomoses, surgical connections between two sections of the gastrointestinal tract. After bowel surgery, surgeons need to verify that the surgical join is sealed and won't leak. Introducing methylene blue solution into the proximal end of the connection and checking for blue staining in areas where it shouldn't appear is a direct, visual leak test. The dye shows up instantly and clearly against tissue and body fluids.

The same property makes methylene blue useful for identifying fistulas, abnormal passages connecting structures that shouldn't be connected. Urologists inject methylene blue intravenously to test ureteral patency and diagnose genitourinary fistulas. The dye follows fluid flow and reveals connections that shouldn't exist through visible blue staining.

Historically, the methylene blue test was used to detect bilirubin in urine. Elevated urinary bilirubin indicates liver dysfunction or bile duct obstruction. A 1947 study in the New England Journal of Medicine documented this test, though modern labs use more precise enzymatic methods now.

For kidney function assessment, intravenous methylene blue was used to test renal tubular function through selective excretion. Because methylene blue is filtered and excreted by the kidneys at a predictable rate, measuring the time to blue urine appearance after IV administration gave clinicians information about renal clearance. This application is largely obsolete now, replaced by more precise creatinine and GFR testing.

For supplement users, this clinical context matters because it underscores something important: oral methylene blue at longevity doses is fundamentally different from IV methylene blue at clinical doses. Most of the serotonin syndrome case reports, the drug interaction warnings, and the dose-toxicity data come from IV administration at much higher doses than longevity supplementation uses. The risk profile at 4-30 mg taken orally is substantially more favorable than the clinical literature on high-dose IV use might suggest. This doesn't mean risks are absent. It means context matters when reading the literature.

Interpreting the methylene blue test on G6PD deficiency

There's one genetic condition that changes the risk calculus entirely: G6PD deficiency.

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in humans, affecting an estimated 400 million people worldwide, with highest prevalence in populations from sub-Saharan Africa, the Mediterranean, and Southeast Asia. It's an X-linked recessive condition, meaning males are more affected than females.

G6PD is required for the reduction of methylene blue to leucomethylene blue inside red blood cells. In G6PD-deficient individuals, methylene blue cannot be adequately reduced and instead causes hemolysis: the destruction of red blood cells. High-dose IV methylene blue has caused severe hemolytic anemia in G6PD-deficient patients. The FDA's methylene blue warnings specifically call out G6PD deficiency as a contraindication at IV doses.

At oral longevity doses, the risk is considerably lower, but G6PD deficiency remains a relevant consideration.

If you have ancestry from high-prevalence populations and haven't been tested, a simple blood test from your doctor will confirm your G6PD status. This is worth knowing before adding methylene blue to a daily protocol, not because the risk at low doses is necessarily prohibitive, but because it's information you should have. Your physician can help you make the risk-benefit assessment based on your actual status.

The supplement interaction checker is useful for flagging known compound interactions, though individual genetic factors like G6PD status require clinical assessment beyond what any supplement tool can provide.

Dosing and the self-test protocol

If you're starting methylene blue and want to run a practical self-assessment, here's a structured approach.

Week 1, days 1-3: start at 4 mg

The lowest effective dose. This establishes your personal baseline and lets you check your response before increasing. Log any subjective effects. Note urine color and timing. Check for side effects, particularly headache or nausea, which some users experience at any dose and which usually resolve within a few days.

Week 1, days 4-7: assess and hold or increase to 8 mg

If you tolerated 4 mg well and saw some signal, you can increase to 8 mg. If you had adverse effects, stay at 4 mg for another week. If you saw no effects at all and no side effects, 8 mg is a reasonable next step.

Weeks 2-4: titrate to your range

Most users find their working range somewhere between 8-20 mg for cognitive and mitochondrial support. Some biohackers and longevity researchers work at the lower end of this range deliberately, on the basis that the hormetic benefit may be strongest below 10 mg where the electron cycling effect isn't overwhelmed.

At each step, run your cognitive tracking. How's your focus at 2-3 hours post-dose? Any change in cognitive endurance during demanding work? These are the short-term signals worth tracking.

Month 1 biomarker test

After a month of consistent daily use, a basic metabolic panel and inflammation markers give you a biological snapshot. HbA1c and fasting glucose show metabolic function. hsCRP shows inflammation. You won't see dramatic changes in a month from methylene blue alone, but the data gives you a baseline to compare against at six months.

For delivery format considerations, the methylene blue dosage dropper guide and the how many drops of methylene blue guide cover liquid dosing specifics, and the best methylene blue capsules guide covers the capsule format for those who prefer precise, no-mess dosing.

Not sure how methylene blue fits into your broader longevity protocol? The WinAging AI protocol builder designs a personalized stack based on your goals, current supplements, and health profile.

Stacking methylene blue: interaction tests you should run

Before adding methylene blue to an existing supplement stack, a few quick tests are worth running.

The serotonergic check: Are you currently taking any SSRI, SNRI, tricyclic antidepressant, MAOI, tramadol, or linezolid? If yes, methylene blue is not safe to combine without physician oversight. This isn't a supplement interaction you can work around. It's a pharmacological contraindication.

The G6PD check: As discussed above. Particularly relevant if you have relevant ancestry or have never been tested.

The lithium check: High-dose methylene blue in combination with lithium (used for bipolar disorder) may affect renal lithium clearance. If you're on lithium therapy, physician consultation is required before any methylene blue use.

The full stack check: Run your current stack through the supplement interaction checker to identify any flagged combinations. Then add methylene blue and re-run.

The good news: methylene blue stacks cleanly with most common longevity compounds. NMN and NR (NAD+ precursors), berberine, creatine, glycine, taurine, and standard foundational supplements like vitamin D, omega-3, and magnesium all combine without known interaction concerns. Some stacks are actively synergistic: methylene blue plus creatine covers both the electron transport chain and ATP regeneration pathways. Methylene blue plus NAD+ precursors covers mitochondrial function from two complementary directions.

For an overview of where methylene blue fits in the broader longevity compound landscape, the methylene blue tablets guide provides the full mechanistic foundation.

And for broader context on individual longevity compounds: the berberine complex guide is an excellent companion read for anyone focused on metabolic optimization, while the glycine and taurine guide covers two amino acids that complement methylene blue's mitochondrial work from a different angle.

Reading the research: what clinical tests actually show

A brief summary of the most relevant clinical findings, because understanding the evidence base is its own kind of test.

The memory trial. A randomized double-blind trial in 26 healthy subjects administered a single 280 mg oral dose of methylene blue and measured brain activity via fMRI. The methylene blue group showed 7% improvement in memory retrieval compared to placebo, with measurable increases in activity in brain regions governing short-term memory and sustained attention. This is a high single dose relative to daily longevity supplementation, but the effect was statistically significant and mechanistically consistent with the compound's known brain activity.

The cytochrome oxidase studies. Multiple animal studies demonstrate that methylene blue preserves cytochrome oxidase (complex IV) activity under conditions that impair mitochondrial function, including hypoperfusion and oxidative stress. In one study, methylene blue completely prevented neurodegeneration and memory impairment in rats with chronic cerebral hypoperfusion. The mechanism is the same one active at low doses in humans: supporting electron flow through the mitochondrial chain.

The Alzheimer's trials. Phase II clinical trials testing a methylene blue derivative (LMTM) in Alzheimer's disease patients showed modest cognitive benefit over six months in some subgroups. The results were inconsistent across the full cohort, complicated by the unusual finding that adding LMTM to existing Alzheimer's medications produced worse outcomes than LMTM alone. These trials are not directly applicable to healthy longevity supplementation, but they provide evidence of cognitive effects in human subjects with compromised neurological function.

The mitochondrial cell studies. In vitro studies show methylene blue produces 30-37% increases in cellular oxygen consumption and up to 70% increases in ATP production at low concentrations. These effects occur directly through the alternative electron transfer mechanism in the mitochondrial chain, cycling between the oxidized and reduced forms to shuttle electrons independently of the standard NADH pathway.

The cumulative picture is this: methylene blue has genuine, mechanistically grounded biological effects on mitochondrial function. Human evidence at longevity-range doses is limited relative to animal and cell studies, but the mechanism is established, the safety profile at low doses is well-documented, and subjective reports from biohackers who track their effects carefully are largely consistent with the research.

Want to understand where you stand before making changes to your protocol? The WinAging tools include a biological age calculator to establish your baseline and a supplement interaction checker to verify your current stack.

Frequently asked questions

Does blue urine mean the methylene blue is working?

Not necessarily. Blue or green urine confirms the compound is present in your system and being cleared by your kidneys. It says nothing about whether you're experiencing the mitochondrial or cognitive benefits. Your body converts part of the methylene blue to a colorless active form, so clear urine doesn't mean the compound isn't working either.

How long does it take for urine to turn blue after taking methylene blue?

Most users see the color change 2-6 hours after taking oral methylene blue. The timing depends on absorption rate, which varies with capsule versus liquid form and whether you took it with or without food. Liquid drops typically absorb faster than capsules.

Can methylene blue affect a drug test?

Standard drug screens don't test for methylene blue, and it produces no metabolites that cross-react with opioid, cannabis, amphetamine, or cocaine panels. However, the blue or green urine color may prompt a testing technician to flag the sample for unusual appearance. Disclosing methylene blue use before the test avoids any complications.

What should I look for on a Certificate of Analysis for methylene blue?

A legitimate CoA should include a batch-specific lot number, assay result between 98-103%, specific heavy metal measurements for arsenic (under 2.15 ppm) and copper (under 55 ppm), residual solvent test results, and the testing laboratory's name and accreditation. It should be dated and lot-specific. A generic template document that applies to no specific production batch is not adequate.

What is the clinical methylene blue test used for in medicine?

Clinically, methylene blue is used to test anastomosis integrity after bowel surgery, identify genitourinary fistulas, and historically to assess renal tubular function and detect urinary bilirubin. These diagnostic applications rely on the dye's visibility in fluid and tissue. They're unrelated to the longevity and cognitive applications of low-dose oral supplementation.

What's the difference between reagent grade and USP grade methylene blue?

Reagent grade is manufactured for laboratory use and legally contains heavy metals including arsenic, lead, and mercury at concentrations that would fail pharmaceutical testing. USP grade is manufactured for human use, with strict heavy metal limits, verified purity in the 98-103% range, and GMP manufacturing requirements. Only USP grade is appropriate for oral supplementation. The heavy metals reagent vs USP grade guide covers this in full detail.

Can I test my methylene blue at home?

Visual inspection gives you limited information: pharmaceutical-grade liquid should be clear and bright blue-violet. Brownish or cloudy solution suggests degradation or contamination. For meaningful quality verification, you need a batch-specific Certificate of Analysis from the manufacturer or an independent laboratory. Home chemistry testing for heavy metals at ppm levels isn't practical without specialized equipment.

What if I'm G6PD deficient, can I still take methylene blue?

G6PD deficiency significantly changes the risk profile for methylene blue use. At IV clinical doses, methylene blue can cause severe hemolysis in G6PD-deficient individuals. At oral longevity doses, the risk is lower but not zero. This is a conversation to have with your physician based on your actual G6PD status, not a decision to make based on general information.

Related guides

• USP grade methylene blue: the complete guide
• Methylene blue tablets: benefits, dosing, and safety
• Best methylene blue capsules: what to look for
• Supplement interaction checker
• Methylene blue red light therapy: the synergy explained

Sources

• MedlinePlus: Methylene blue test
• PMC: Methylene blue modulates functional connectivity in the human brain
• RSNA: Methylene blue shows promise for improving short-term memory

---

The methylene blue test question is almost always really several questions at once: did it absorb, is this product real, will it cause problems on a drug screen? The answers are distinct. Blue urine confirms presence, not effect. A CoA with batch-specific lab results confirms quality. And standard drug panels don't test for methylene blue, though the color change is worth disclosing.

Get your quality verification sorted before worrying about urine color. That's the test that actually matters.

Explore the WinAging tools to track your biomarkers and build a longevity protocol around what the evidence supports. Or use the AI protocol builder to get a personalized methylene blue stack recommendation based on your goals and health profile.